Viewing Study NCT01782235


Ignite Creation Date: 2025-12-24 @ 10:43 PM
Ignite Modification Date: 2025-12-25 @ 8:14 PM
Study NCT ID: NCT01782235
Status: COMPLETED
Last Update Posted: 2019-08-21
First Post: 2013-01-30
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Efficacy of Tocilizumab in Primary Sjögren's Syndrome.
Sponsor: University Hospital, Strasbourg, France
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module